Host: |
Mouse |
Applications: |
IHC/WB |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-Keratin, type I cytoskeletal 13 (400-458 aa) is suitable for use in Immunohistochemistry and Western Blot research applications. |
Clonality: |
Monoclonal |
Clone ID: |
ABT-CK13 |
Conjugation: |
Unconjugated |
Isotype: |
IgG1k |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. |
Dilution Range: |
IHC-P 1:100-500WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
KRT13 |
Gene ID: |
3860 |
Uniprot ID: |
K1C13_HUMAN |
Immunogen Region: |
400-458 aa |
Specificity: |
This antibody detects endogenous levels of human Cytokeratin 13. Heat-induced epitope retrieval (HIER) Citrate buffer of pH6.0 was highly recommended as antigen repair method in paraffin section |
Immunogen: |
Synthesized peptide derived from the human Cytokeratin 13 at the amino acid range 400-458 |
Post Translational Modifications | O-glycosylated.glycans consist of single N-acetylglucosamine residues. |
Function | Type 1 keratin (Probable). Maintains postnatal tongue mucosal cell homeostasis and tissue organization in response to mechanical stress, potentially via regulation of the G1/S phase cyclins CCNE1 and CCNE2. |
Protein Name | Keratin - Type I Cytoskeletal 13Cytokeratin-13Ck-13Keratin-13K13 |
Database Links | Reactome: R-HSA-6805567Reactome: R-HSA-6809371 |
Alternative Antibody Names | Anti-Keratin - Type I Cytoskeletal 13 antibodyAnti-Cytokeratin-13 antibodyAnti-Ck-13 antibodyAnti-Keratin-13 antibodyAnti-K13 antibodyAnti-KRT13 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance